Changing to Avastin could save NHS £100m a year - Cameron Optometry | Cameron Optometry
Changing to Avastin could save NHS £100m a year

Changing to Avastin could save NHS £100m a year

Posted on 25th November 2014

The drug Avastin has been in the newscalling for its use in the UK in a bid to save millions each year.

eye-care

Popular in the US, Avastin is used for patients with age-related macular degeneration (AMD). It has been on the market for years, gone through all the testing and has been proven to be as effective as Lucentis, the NHS approved drug for the same condition. The difference is cost. Lucentis typically costs around £700 per treatment, compared to Avastin which is about £70. Yet red tape seems to be halting its use.

It is currently unlicensed in the UK so should anything go wrong with its use, the practitioner may not be legally covered. However, in times of austerity and it is perhaps time for the NHS to move forward and license its use.


Related Posts

Gillian Bruce completes masters as top performing student

18th June 2018

We’re thrilled to announce that our clinical lead optometrist, Gillian Bruce, has passed her Masters of Science (MSc) degree in Primary Care Ophthalmology with distinction. As if that wasn’t impre...

Read more

Update: Our successful Myopia Management programme

24th May 2018

When we first wrote in our blog about Myopia Management over two years ago, it was all quite new. Cameron Optometry was one of the first optometrists in the UK to set up a Myopia Management programme ...

Read more

New sunglasses trends

01st May 2018

A couple of months later than we'd hoped, but spring is now here to stay! It’s time to get your frame on and start thinking about the ultimate statement accessory - we’re talking sunglasses, of co...

Read more

We won!

16th April 2018

We are thrilled to announce that we have won the Practice Growth Award at the national UK Optician Awards. The highly regarded awards, recognise excellence in the optical industry.  This award is ...

Read more